.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.

The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.


NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreAll authorized local manufacturers are hereby informed that a Public Day will be held on Wednesday, 18 November 2026, at 1.00 p.m.
The purpose of this meeting is to provide an opportunity for authorized local manufacturers to discuss on matters relating to the price evaluation of medicinal products manufactured locally.
All authorized local manufacturers are kindly requested to attend and participate in the meeting.
Thank you
CEO, NMRA
Notice to all Authorized Local Agents,
This is to kindly inform all authorized local agents that the USD rate considered for the month of November-2026 for processing price details of medicines/ medical devices is 334.99
Please ensure that all price submissions for MRP approvals are prepared accordingly.
The Ministry of Health & Mass Media (the Purchaser) invites sealed bids from eligible bidders for the procurement of the following IT products. A brief description of the types of IT products is below :
Procurement of an IT Solution for Dossier Evaluation, Retail Pharmacy Regulation, and Auxiliary Regulatory Functions, Including Capacity Building for National Medicines Regulatory Authority (NMRA) of Sri Lanka.
Click Here : Adverticement
Minor variation requiring notification (MIV1.N) related to medicines should only be submitted to the Medicines Accepting Counter with the relevant documents, in accordance with the published NMRA variation guideline.
Notifications (MIV1.N) submitted in any other formats (eg: letters) are not accepted for consideration.